Tiziana Life Sciences (TLSA) Enterprise Value Growth (5y) (2022 - 2025)

Tiziana Life Sciences (TLSA) Enterprise Value Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,222.41 Bn 67,222.13 Bn -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.12 Bn 466.33 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.84 Bn 114.59 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.89 Bn 61.14 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 55.83 Bn 50.64 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.34 Bn 34.34 Bn 959.66 Mn
10 Tiziana Life Sciences 110.93 Mn 106.92 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 42.48%
Jun 30, 2025 4.10%
Dec 31, 2024 -80.07%
Jun 30, 2024 22.82%
Dec 31, 2023 31.97%
Jun 30, 2023 -136.67%
Dec 31, 2022 -212.50%